Evidence map›Paper›PMID 30684162›Full record

ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2019

Comparison between Vitek MS, Bruker Biotyper, Vitek2, and API20E for differentiation of species of the genus Raoultella.

Carlos Ruiz de Alegría Puig, Marina Fernández Torres, Eduardo Marfil-Pérez, María Isabel Rodríguez Ferández, Manuel Causse Del Río, Jesús Agüero Balbín, Luis Martínez-Martínez

Abstract readComparative StudyEvaluation Study
PubMed Publisher
In one paragraph

Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. First Case ofMedicina (Kaunas, Lithuania) · 2023
    Article
  3. Case Report: Multidrug ResistantFrontiers in veterinary science · 2021
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Carlos Ruiz de Alegría PuigMicrobiology Service, University Hospital Marqués de Valdecilla-IDIVAL, Santander, Spain. carlosrdap@hotmail.com.ORCID http://orcid.org/0000-0002-2892-8359
Marina Fernández TorresMicrobiology Service, University Hospital Marqués de Valdecilla-IDIVAL, Santander, Spain.
Eduardo Marfil-PérezClinical Unit, University Hospital Reina Sofía, Córdoba, Spain.
María Isabel Rodríguez FerándezMicrobiology Service, University Hospital Marqués de Valdecilla-IDIVAL, Santander, Spain.
Manuel Causse Del RíoClinical Unit, University Hospital Reina Sofía, Córdoba, Spain.
Jesús Agüero BalbínMicrobiology Service, University Hospital Marqués de Valdecilla-IDIVAL, Santander, Spain.
Luis Martínez-MartínezClinical Unit, University Hospital Reina Sofía, Córdoba, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rapid and reliable identification of microorganisms in the clinical laboratory is essential for an early and accurate diagnosis guiding timely therapy. However, conventional methods are sometimes unreliable and show controversial outcomes. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) has been reported as a rapid and reliable method for identification of bacteria and fungi isolated from clinical samples. Members of the genus Raoultella are increasingly recognized as clinically relevant. There are difficulties in their identification at the species level since sequencing the 16S rRNA or the rpoB genes does not show conclusive results. The aim of this study has been to compare two MALDI-TOF MS systems (Vitek MS and Bruker Biotyper) with Vitek2 and API20E systems for differentiation of Raoultella species. A collection of 97 clinical isolates of Raoultella species was identified with Vitek MS, in parallel with Vitek2 and API, and finally with Bruker Biotyper. Among the two most widely used MALDI-TOF MS platforms, results obtained with Vitek MS were slightly superior to those obtained with the Bruker Biotyper system, with sensitivities and specificities of 98.9/57.9% and 98.8/37.0%, respectively. The current commercial phenotypic identification systems are not optimized for the identification of Raoultella species. Our results indicate that MALDI-TOF-based identification is more accurate and sensitive than that provided by phenotypic methods.

Indexed as

Bacterial Typing TechniquesEnterobacteriaceaeEnterobacteriaceae InfectionsHumansMolecular TypingSensitivity and SpecificitySpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationTime FactorsBruker BiotyperMALDI-TOF MSRaoultellaVitek MS

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.